Skip to main content
Premium Trial:

Request an Annual Quote

Lilly to Use Exosome Diagnostics' Nucleic Acid Extraction Kit for Biomarker Research

Premium

Exosome Diagnostics this week announced that it has signed a deal to collaborate with Eli Lilly on mRNA and microRNA biomarker discovery and validation.

Under the arrangement, Lilly will have early access to Exosome's EXO50 nucleic acid extraction kit, which isolates both mRNA and microRNA, and can distinguish between exosomal microRNA and protein-complexed microRNA. It will use the technology to identify gene mutations and expression levels in blood that may be correlated with drug response and disease recurrence.

Financial terms of the arrangement were not disclosed.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.